|
liver transplantation |
15 |
|
hepatocellular carcinoma |
8 |
|
inflammation |
8 |
|
tumor recurrence |
8 |
|
cytokines |
6 |
|
gpx3 |
6 |
|
inflammasomes |
6 |
|
kc |
6 |
|
neutrophil |
6 |
|
post-lt surveillance |
6 |
|
rap1 |
6 |
|
adenosinergic signaling pathway |
5 |
|
apoptosis |
5 |
|
entpd1/cd39 |
5 |
|
et5e/cd73 |
5 |
|
extracellular adenosine |
5 |
|
hepatic ischemia reperfusion injury |
5 |
|
hepatic senescence |
5 |
|
hipsc-mscs |
5 |
|
inflammatory response |
5 |
|
ir injury |
5 |
|
liver graft injury |
5 |
|
momp |
5 |
|
neutrophils |
5 |
|
neutrophils migration |
5 |
|
nf-κb signaling |
5 |
|
nuclear factor-κb |
5 |
|
regulatory t cells |
5 |
|
t cell exhaustion |
5 |
|
chemoresistance |
4 |
|
cisplatin |
4 |
|
clinical outcomes |
4 |
|
complement component |
4 |
|
diagnosis prediction |
4 |
|
hcc |
4 |
|
hcc invasiveness |
4 |
|
hemoglobin-based oxygen carrier |
4 |
|
inflammasome |
4 |
|
intravital imaging |
4 |
|
lipid metabolism |
4 |
|
mdsc |
4 |
|
mitochondrion |
4 |
|
response marker |
4 |
|
steatosis |
4 |
|
steatotic liver graft |
4 |
|
therapeutic potential |
4 |
|
therapeutic target |
4 |
|
transmembrane protein 47 |
4 |
|
tumor-suppressive protein |
4 |
|
tumour recurrence |
4 |
|
biomarker |
3 |
|
cell delivery |
3 |
|
early allograft dysfunction |
3 |
|
immunology |
3 |
|
in vivo applications |
3 |
|
lactate |
3 |
|
liver cancer |
3 |
|
magnet‐driven |
3 |
|
microrobots |
3 |
|
photoacoustic imaging |
3 |
|
recurrence |
3 |
|
alcoholic liver disease |
2 |
|
ischemia/reperfusion injury |
2 |
|
sobriety |
2 |
|
therapy |
2 |
